• Molecular NameErythrityl Tetranitrate
  • Synonym1,2,3,4-Butanetetralyl tetranitrate; Eritritile tetranitrato [dcit]; Eritrityl tetranitrate; Eritrityli tetranitras [inn-latin]; Erythritol tetranitrate; Erythrol tetranitrate; ETN; Meso-erythritol tetranitrate; Nitroerythrit; Nitroerythrite; Nitroerythrol; Tetranitrate d'eritrityle [inn-french]; Tetranitrato de eritritilo [inn-spanish]
  • Weight302.108
  • Drugbank_IDDB01613
  • ACS_NO7297-25-8
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.41
  • pkaN/A
  • LogD (pH=7, predicted)2.41
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-3.76
  • LogSw (predicted, AB/LogsW2.0)0.26
  • Sw (mg/ml) (predicted, ACD/Labs)0.05
  • No.of HBond Donors0
  • No.of HBond Acceptors16
  • No.of Rotatable Bonds11
  • TPSA232.24
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyDue to the availability of erythritol as a natural sweetener and its relative ease of production in relation to PETN, ETN is a favoured home made explosive compound to the amateur experimenter.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A